Summary
1. A spectrophotofluorometric procedure is described by which the potassium-retaining diuretic amiloride is isolated from the urine by means of thin-layer chromatography. - 2. After administering single doses of 10 mg, the drug can be demonstrated in the urine up to 24 h, and after giving 20 mg, up to 48 h. The percentage recovered is independent of the dosage applied and is not influenced by diuresis, or by the concomitant administration of the saluretic, etacrynic acid. In patients with cirrhosis of the liver and portal hypertension the recovery of amiloride is identical to that of healthy controls. After fasting for four hours following the ingestion of the drug, the quantity of the diuretic excreted in the urine is approximately twice that after administration of amiloride at breakfast or shortly before.
Similar content being viewed by others
Literature
Alter, S., P. Cushman, and J. Hilton: A New Guanidine Diuretic, Amipramizide: Reduction of the Kaliuretic Effect of Ethacrynic Acid in Man. Clin. Pharmacol. Ther. 8, 243–247 (1967).
Baer, J. E., C. M. Mucha, S. A. Spitzer, and H. W. Yee: A K+-sparing Natriuretic Pyrazinamide Derivative. Fed. Proc. 25, 197 (1966).
Brunner, F. P.: Klinische Erfahrungen mit dem neuen kaliumsparenden Diureticum Amilorid (Moduretic, Colectril, MK 870). Schweiz. med. Wschr. 97, 1542–1548 (1967).
Glitzer, M.S., and S.L. Steelman: N-Amidino-3,5-diamino-6-chloropyrazine-carbocamide: an Active Diuretic in the Carboxamide Series. Nature (London) 212, 191–193 (1966).
GomBos, E. A., E. D. Frets, and A. Moghadam: Effects of MK 870 in Normal Subjects and Hypertensive Patients. New Engl. J. Med. 275, 1215–1220 (1967).
Gomez mont, F., L. Landa, C. Ramirez, and A. Perches: Treatment of Ascites due to Cirrhosis with a Derivative of 6-chloropyrazinamide. Gac. med. Méx. 96, 1341–1347 (1966).
Heidland, A., K. Klütsch, u. A. Moormann: Zur renalen Kalium-Retention nach Verabreichung von Amiloride HCl. Arzneimittel-Forsch. 10, 1314–1318 (1967).
Hitzenberger, G., H. Kampffmeyer, and J. Conway: The Diuretic Effect of Desmethyl-pipazuroylguanidine (MK 870) in Man. Clin. Pharmacol. Ther. 9, 71–79 (1968).
Jones, C.B., H. F. Russo, and A. Zacchei: Fate of Pyrazinamide Derivatives with Natriuretic Activity. Fed. Proc. 25, 197 (1966).
Lundvall, O., and S. Berlind: Clinical Trial of a Potassium-sparing Saluretic Pyrazine Derivative (MK 870). Acta med. stand. 181, 457–463 (1967).
Moukheibir, N.W., and W.M. Kirkendall: Effect of Amipramizide (MK 870) on Electrolyte and Water Balance in Patients with Cirrhosis of the Liver. Clin. Res. Proc. 13, 425 (1965).
Reynolds, T. B., and H. C. Pelle: Effects of a New Diuretic Amipramidine (MK 870) in Patients with Cirrhosis and Ascites. Clin. Res. Proc. 14, 184 (1966).
Schmid, E., J. Adlung, G. Fricke u. G. Stoffels: Klinisch-pharmakologische Untersuchungen über die Arzneimittelresorption bei Lebererkrankungen. Verh. dtsch. Ges. inn. Med. 74, (1968, in print).
Senewiratne, B., and S. Sherlock: Amiloride (MK 870) in Patients with Ascites due to Cirrhosis of the Liver. Lancet 1968 I, 120–122.
Singh, B.N., D.E. Richmond, J.D. Wilson, and H.A. Simmonds: Evaluation of MK 870: a New Potassium-sparing Diuretic. Brit. med. J. 1967 I, 143–146.
Sperber, R. J., and S. Fisch: Studies with MK 870 — a New, Non-steroid Potassium-sparing Diuretic. Clin. Res. Proc. 14, 262 (1966).
Stahl, E.: Dünnschichtchromatographie. Ein Laboratoriumshandbuch; 2. Aufl. Berlin-Heidelberg-New York: Springer-Verlag, 1967.
Stone, C. A.: Personal communication, Nov. 1964.
Udenfriend, S.: Fluorescence Assay in Biology and Medicine. New York-London: Academic Press 1964.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmid, E., Fricke, G. Studies on urinary excretion of the potassium-retaining diuretic amiloride (Desmethyl-pipazuroyl-guanidine, MK 870) in man. Pharmacol. Clin. 1, 110–113 (1969). https://doi.org/10.1007/BF00404655
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00404655